Cathay Capital Private Equity is raising what it claims is China's first-ever smart energy fund, relying on contributions from LPs that offer strategic as well as financial support
When Cathay Capital Private Equity launched its China car technology fund in 2017 – the firm’s first renminbi-denominated vehicle – French auto supplier Valeo came in as an anchor investor. It inspired...
Increased climate change awareness on a corporate level is leading to more investment – either direct or through funds – in start-ups that offer mitigation solutions. Asia is a key geography
Healthcare-focused Panacea Venture has led a $40 million Series C round for China’s XWPharma, a neurobiology-focused biotech developer previously known as XW Laboratories.
Kyee Technology, a Chinese digital medical platform has raised RMB430 million ($64 million) in a Series D round led by Tencent Holdings. Other investors include Longmen Capital, Dyee Capital and Royal Sea Capital.
Biocytogen, a Chinese contract research organization (CRO) that provides genetically-modified mice for drug testing, has raised RMB970 million ($143 million) in an extended tranche of Series D funding.